Literature DB >> 20682782

The pseudo signal peptide of the corticotropin-releasing factor receptor type 2a decreases receptor expression and prevents Gi-mediated inhibition of adenylyl cyclase activity.

Katharina Schulz1, Claudia Rutz, Carolin Westendorf, Ingrid Ridelis, Susanne Vogelbein, Jens Furkert, Antje Schmidt, Burkhard Wiesner, Ralf Schülein.   

Abstract

The corticotropin-releasing factor receptor type 2a (CRF(2(a))R) belongs to the family of G protein-coupled receptors. The receptor possesses an N-terminal pseudo signal peptide that is unable to mediate targeting of the nascent chain to the endoplasmic reticulum membrane during early receptor biogenesis. The pseudo signal peptide remains uncleaved and consequently forms an additional hydrophobic receptor domain with unknown function that is unique within the large G protein-coupled receptor protein family. Here, we have analyzed the functional significance of this domain in comparison with the conventional signal peptide of the homologous corticotropin-releasing factor receptor type 1 (CRF(1)R). We show that the presence of the pseudo signal peptide leads to a very low cell surface receptor expression of the CRF(2(a))R in comparison with the CRF(1)R. Moreover, whereas the presence of the pseudo signal peptide did not affect coupling to the G(s) protein, G(i)-mediated inhibition of adenylyl cyclase activity was abolished. The properties mediated by the pseudo signal peptide were entirely transferable to the CRF(1)R in signal peptide exchange experiments. Taken together, our results show that signal peptides do not only influence early protein biogenesis. In the case of the corticotropin-releasing factor receptor subtypes, the use of conventional and pseudo signal peptides have an unexpected influence on signal transduction.

Mesh:

Substances:

Year:  2010        PMID: 20682782      PMCID: PMC2963340          DOI: 10.1074/jbc.M110.129627

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Chaperone selection during glycoprotein translocation into the endoplasmic reticulum.

Authors:  M Molinari; A Helenius
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

2.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.

Authors:  S R George; T Fan; Z Xie; R Tse; V Tam; G Varghese; B F O'Dowd
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

3.  The signal peptide of the G protein-coupled human endothelin B receptor is necessary for translocation of the N-terminal tail across the endoplasmic reticulum membrane.

Authors:  Robert Köchl; Martina Alken; Claudia Rutz; Gerd Krause; Alexander Oksche; Walter Rosenthal; Ralf Schülein
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

Review 4.  International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands.

Authors:  Richard L Hauger; Dimitri E Grigoriadis; Mary F Dallman; Paul M Plotsky; Wylie W Vale; Frank M Dautzenberg
Journal:  Pharmacol Rev       Date:  2003-03       Impact factor: 25.468

5.  Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.

Authors:  M Mellado; J M Rodríguez-Frade; A J Vila-Coro; S Fernández; A Martín de Ana; D R Jones; J L Torán; C Martínez-A
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

6.  The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process.

Authors:  Evelina Grantcharova; Jens Furkert; H Peter Reusch; Hans-Willi Krell; Gisela Papsdorf; Michael Beyermann; Ralf Schulein; Walter Rosenthal; Alexander Oksche
Journal:  J Biol Chem       Date:  2002-09-10       Impact factor: 5.157

7.  Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells.

Authors:  Doreen Wietfeld; Nadja Heinrich; Jens Furkert; Klaus Fechner; Michael Beyermann; Michael Bienert; Hartmut Berger
Journal:  J Biol Chem       Date:  2004-07-12       Impact factor: 5.157

8.  Improved prediction of signal peptides: SignalP 3.0.

Authors:  Jannick Dyrløv Bendtsen; Henrik Nielsen; Gunnar von Heijne; Søren Brunak
Journal:  J Mol Biol       Date:  2004-07-16       Impact factor: 5.469

9.  Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory.

Authors:  Andrew C Charles; Natalya Mostovskaya; Kathleen Asas; Christopher J Evans; Megan L Dankovich; Tim G Hales
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

Review 10.  Topogenesis of membrane proteins at the endoplasmic reticulum.

Authors:  Marie Higy; Tina Junne; Martin Spiess
Journal:  Biochemistry       Date:  2004-10-12       Impact factor: 3.162

View more
  18 in total

1.  Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents.

Authors:  Guillaume Gourcerol; S Vincent Wu; Pu-Qing Yuan; Hung Pham; Marcel Miampamba; Muriel Larauche; Paul Sanders; Tomofumi Amano; Agata Mulak; Eunok Im; Charalabos Pothoulakis; Jean Rivier; Yvette Taché; Mulugeta Million
Journal:  Gastroenterology       Date:  2011-01-26       Impact factor: 22.682

2.  The Pseudo signal peptide of the corticotropin-releasing factor receptor type 2A prevents receptor oligomerization.

Authors:  Anke Teichmann; Claudia Rutz; Annika Kreuchwig; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

3.  The specific monomer/dimer equilibrium of the corticotropin-releasing factor receptor type 1 is established in the endoplasmic reticulum.

Authors:  Anke Teichmann; Arthur Gibert; André Lampe; Paul Grzesik; Claudia Rutz; Jens Furkert; Jan Schmoranzer; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

4.  Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase.

Authors:  J L Lukkes; D R Staub; A Dietrich; W Truitt; A Neufeld-Cohen; A Chen; P L Johnson; A Shekhar; C A Lowry
Journal:  Neuroscience       Date:  2011-03-29       Impact factor: 3.590

5.  Cellular adaptations of dorsal raphe serotonin neurons associated with the development of active coping in response to social stress.

Authors:  Susan K Wood; Xiao-Yan Zhang; Beverly A S Reyes; Catherine S Lee; Elisabeth J Van Bockstaele; Rita J Valentino
Journal:  Biol Psychiatry       Date:  2013-02-26       Impact factor: 13.382

6.  CRF binding protein facilitates the presence of CRF type 2α receptor on the cell surface.

Authors:  Paula G Slater; Cledi A Cerda; Luis A Pereira; María E Andrés; Katia Gysling
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

7.  Dopamine D1 and corticotrophin-releasing hormone type-2α receptors assemble into functionally interacting complexes in living cells.

Authors:  J Fuenzalida; P Galaz; K A Araya; P G Slater; E H Blanco; J M Campusano; F Ciruela; K Gysling
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

8.  Misfolding Ectodomain Mutations of the Lutropin Receptor Increase Efficacy of Hormone Stimulation.

Authors:  E Charmandari; R Guan; M Zhang; L G Silveira; Q R Fan; G P Chrousos; A C Sertedaki; A C Latronico; D L Segaloff
Journal:  Mol Endocrinol       Date:  2015-11-10

9.  Defining a conformational consensus motif in cotransin-sensitive signal sequences: a proteomic and site-directed mutagenesis study.

Authors:  Wolfgang Klein; Carolin Westendorf; Antje Schmidt; Mercè Conill-Cortés; Claudia Rutz; Marcus Blohs; Michael Beyermann; Jonas Protze; Gerd Krause; Eberhard Krause; Ralf Schülein
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

10.  The regions within the N-terminus critical for human glucagon like peptide-1 receptor (hGLP-1R) cell surface expression.

Authors:  Aiysha Thompson; Venkateswarlu Kanamarlapudi
Journal:  Sci Rep       Date:  2014-12-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.